4//SEC Filing
Apelian David 4
Accession 0001209191-20-018973
CIK 0001305253other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:20 PM ET
Size
7.1 KB
Accession
0001209191-20-018973
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-03-12+10,000→ 10,000 totalExercise: $5.60Exp: 2030-03-11→ Common Stock (10,000 underlying) - Award
Common Stock
2020-03-12+5,000→ 5,000 total
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2020.
- [F2]The option vests in equal monthly installments over 12 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001546842
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:20 PM ET
- Size
- 7.1 KB